Latest Drugs, Latest Approval in Integrase strand transfer inhibitor

What are Integrase strand transfer inhibitor?

Integrase strand transfer inhibitors block the action of integrase, a viral enzyme of the human immunodeficiency virus Type 1 (HIV-1), that is involved in integrating viral DNA into the host chromosome. Integration of the viral DNA into the host DNA is necessary for viral replication. Integrase strand transfer inhibitors is not a cure for HIV or AIDS but is used to prevent human immunodeficiency virus from multiplying in the host.

Name Updated
Cabotegravir (Cabotegravir [ ka-boe-teg-ra-vir ]) 15-Aug-2023
Dolutegravir (Dolutegravir [ doe-loo-teg-ra-vir ]) 14-Aug-2023
Raltegravir (Raltegravir [ ral-teg-ra-veer ]) 12-Aug-2023
Apretude (Cabotegravir) 05-Aug-2023
Tivicay pd (Dolutegravir [ doe-loo-teg-ra-vir ]) 05-Aug-2023
Tivicay (Dolutegravir [ doe-loo-teg-ra-vir ]) 05-Aug-2023
Vocabria (Cabotegravir [ ka-boe-teg-ra-vir ]) 14-Jul-2023
Vitekta (Elvitegravir [ el-vi-teg-ra-vir ]) 14-Jul-2023
Isentress (Raltegravir [ ral-teg-ra-veer ]) 13-Jul-2023